Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study

Background & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Umberto Vespasiani-Gentilucci, Chiara Dell’Unto, Antonio De Vincentis, Andrea Baiocchini, Marco Delle Monache, Roberto Cecere, Adriano Maria Pellicelli, Valerio Giannelli, Simone Carotti, Giovanni Galati, Paolo Gallo, Francesco Valentini, Franca Del Nonno, Davide Rosati, Sergio Morini, Raffaele Antonelli-Incalzi, Antonio Picardi
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2018/7564835
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552811704877056
author Umberto Vespasiani-Gentilucci
Chiara Dell’Unto
Antonio De Vincentis
Andrea Baiocchini
Marco Delle Monache
Roberto Cecere
Adriano Maria Pellicelli
Valerio Giannelli
Simone Carotti
Giovanni Galati
Paolo Gallo
Francesco Valentini
Franca Del Nonno
Davide Rosati
Sergio Morini
Raffaele Antonelli-Incalzi
Antonio Picardi
author_facet Umberto Vespasiani-Gentilucci
Chiara Dell’Unto
Antonio De Vincentis
Andrea Baiocchini
Marco Delle Monache
Roberto Cecere
Adriano Maria Pellicelli
Valerio Giannelli
Simone Carotti
Giovanni Galati
Paolo Gallo
Francesco Valentini
Franca Del Nonno
Davide Rosati
Sergio Morini
Raffaele Antonelli-Incalzi
Antonio Picardi
author_sort Umberto Vespasiani-Gentilucci
collection DOAJ
description Background & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three study populations, that is, patients diagnosed with NASH-cirrhosis or with noncirrhotic NAFLD and healthy controls, were enrolled. PNPLA3 rs738409, TM6SF2 rs58542926, KLF6 rs3750861, SOD2 rs4880, and LPIN1 rs13412852 were genotyped. Results. One hundred and seven NASH-cirrhotics, 93 noncirrhotic NAFLD, and 90 controls were enrolled. At least one difference in allele frequency between groups was significant, or nearly significant, for the PNPLA3, TM6SF2, and KLF6 variants (p<0.001, p<0.05, and p=0.06, resp.), and a risk score based on these SNPs was generated. No differences were observed for SOD2 and LPIN1 SNPs. When compared to a score of 0, a score of 1-2 quadrupled, and a score of 3-4 increased 20-fold the risk of noncirrhotic NAFLD; a score of 3-4 quadrupled the risk of NASH-cirrhosis. Conclusions. The effects determined by disease-associated variants at different loci can add up to multiply the risk of NAFLD and NASH-cirrhosis. Combining different disease-associated variants may represent the way for genetics to keep strength in NAFLD diagnostics.
format Article
id doaj-art-d4b60012130141539a87bcbfd040b534
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-d4b60012130141539a87bcbfd040b5342025-02-03T05:57:46ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972018-01-01201810.1155/2018/75648357564835Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept StudyUmberto Vespasiani-Gentilucci0Chiara Dell’Unto1Antonio De Vincentis2Andrea Baiocchini3Marco Delle Monache4Roberto Cecere5Adriano Maria Pellicelli6Valerio Giannelli7Simone Carotti8Giovanni Galati9Paolo Gallo10Francesco Valentini11Franca Del Nonno12Davide Rosati13Sergio Morini14Raffaele Antonelli-Incalzi15Antonio Picardi16Internal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyLaboratory of Pathology of The National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, ItalyHepatology Outpatient Clinic, Colleferro Hospital, Rome, ItalyHepatology Outpatient Clinic, Colleferro Hospital, Rome, ItalyLiver Disease Unit, San Camillo-Forlanini Hospital, Rome, ItalyLiver Disease Unit, San Camillo-Forlanini Hospital, Rome, ItalyLaboratory of Microscopic and Ultrastructural Anatomy, CIR, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyLaboratory of Pathology of The National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, ItalyUniversity La Sapienza of Rome, Rome, ItalyLaboratory of Microscopic and Ultrastructural Anatomy, CIR, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyInternal Medicine, Geriatrics, and Hepatology Unit, University Campus Bio-Medico, Rome, ItalyBackground & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three study populations, that is, patients diagnosed with NASH-cirrhosis or with noncirrhotic NAFLD and healthy controls, were enrolled. PNPLA3 rs738409, TM6SF2 rs58542926, KLF6 rs3750861, SOD2 rs4880, and LPIN1 rs13412852 were genotyped. Results. One hundred and seven NASH-cirrhotics, 93 noncirrhotic NAFLD, and 90 controls were enrolled. At least one difference in allele frequency between groups was significant, or nearly significant, for the PNPLA3, TM6SF2, and KLF6 variants (p<0.001, p<0.05, and p=0.06, resp.), and a risk score based on these SNPs was generated. No differences were observed for SOD2 and LPIN1 SNPs. When compared to a score of 0, a score of 1-2 quadrupled, and a score of 3-4 increased 20-fold the risk of noncirrhotic NAFLD; a score of 3-4 quadrupled the risk of NASH-cirrhosis. Conclusions. The effects determined by disease-associated variants at different loci can add up to multiply the risk of NAFLD and NASH-cirrhosis. Combining different disease-associated variants may represent the way for genetics to keep strength in NAFLD diagnostics.http://dx.doi.org/10.1155/2018/7564835
spellingShingle Umberto Vespasiani-Gentilucci
Chiara Dell’Unto
Antonio De Vincentis
Andrea Baiocchini
Marco Delle Monache
Roberto Cecere
Adriano Maria Pellicelli
Valerio Giannelli
Simone Carotti
Giovanni Galati
Paolo Gallo
Francesco Valentini
Franca Del Nonno
Davide Rosati
Sergio Morini
Raffaele Antonelli-Incalzi
Antonio Picardi
Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
Canadian Journal of Gastroenterology and Hepatology
title Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
title_full Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
title_fullStr Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
title_full_unstemmed Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
title_short Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
title_sort combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis a proof of concept study
url http://dx.doi.org/10.1155/2018/7564835
work_keys_str_mv AT umbertovespasianigentilucci combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT chiaradellunto combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT antoniodevincentis combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT andreabaiocchini combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT marcodellemonache combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT robertocecere combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT adrianomariapellicelli combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT valeriogiannelli combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT simonecarotti combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT giovannigalati combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT paologallo combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT francescovalentini combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT francadelnonno combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT daviderosati combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT sergiomorini combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT raffaeleantonelliincalzi combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy
AT antoniopicardi combininggeneticvariantstoimproveriskpredictionfornafldanditsprogressiontocirrhosisaproofofconceptstudy